Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




LIMS Industry Market Driven by Molecular Diagnostics

By LabMedica International staff writers
Posted on 08 Oct 2013
The market for laboratory information management (LIMS) systems will grow to nearly a USD 1.5 billion market in 2015, according to a report by healthcare market research firm Kalorama Information (New York, NY, USA). More...
The report on Laboratory Information Systems (LIS/LIMS) claims that growth will be driven by the need for clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing. The report covers market information, including forecasts, company profiles, and trend analysis.

Laboratory information systems are data and information management systems designed for industrial and medical-related laboratories, including clinical and analytical laboratories. LIS and LIMS have evolved to become a necessity for both small and large diagnostic and drug company laboratories, to allow users to obtain, store, manage, retrieve, and record laboratory data. But data coming into the lab from patients regarding their medical history and previous tests through Emergency Medical Retrieval Services (EMRS) is becoming more complex and has to be merged with new data from current diagnostic tests.

“These systems are no longer merely convenient optional tools to be used in labs,” said Joe Constance, analyst and author of the report. “They are a necessary component of all modern laboratories that desire the combination of processing efficiency, quality assurance, and data validation that are required to be competitive.”

A LIMS traditionally processes data related to batches of samples from genetic, biology, drug development, and clinical trial laboratories. It processes data involving anonymous research-specific laboratory data. Advances in DNA and RNA sequencing technologies and the commercialization of next-generation sequencing instrumentation in recent years has made it possible to automate several steps of laboratory processes, leading to an increased throughput. Consequently, there has been an exponential growth of data generated, along with the evolution of more efficient and complicated procedures and processes in the lab.

The report also notes that some consolidation has occurred among LIS and LIMS vendors. For example, Accelrys, a lab informatics company, has essentially expanded into the LIMS market. Roper Industries acquired Sunquest Information Systems, which provides diagnostic and laboratory information systems to health care providers.

Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services.

Related Links:
Kalorama Information



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.